Concepedia

Publication | Closed Access

5‐azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors

46

Citations

32

References

2010

Year

Abstract

So, this study strongly suggests a therapeutic potential of 5-Aza in combination with anti-androgen therapy in patients with in AR expressing and AR-deficient HRPC.

References

YearCitations

Page 1